Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer (Q63199190)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

author name string

Kathryn Greven

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kathryn Winter

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kelly Underhill

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jim Fontenesci

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jay Cooper

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tom Burke

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

20 March 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

103

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

155-159

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16545437%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement--patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Phase II evaluation of carboplatin in advanced endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Preliminary analysis of RTOG 9708: adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.007

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q63199190&oldid=1829477419"